{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:11:42Z","timestamp":1791335502679,"version":"4.3.1"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T00:00:00Z","timestamp":1539129600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2018.00292","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T00:21:06Z","timestamp":1539130866000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":47,"title":["Aggressive NK-Cell Leukemia"],"prefix":"10.3389","volume":"6","author":[{"given":"Fumihiro","family":"Ishida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,10,10]]},"reference":[{"key":"B1","first-page":"353","article-title":"Aggressive NK-cell leukaemia","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues.","author":"Chan","year":"2017"},{"key":"B2","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood.V87.4.1207.bloodjournal8741207","article-title":"Classification of natural killer (NK) cell and NK-like T-cell malignancies","volume":"87","author":"Jaffe","year":"1996","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.2169\/internalmedicine.56.8881","article-title":"Clinical features, pathogenesis, and treatment of large granular lymphocyte leukemias","volume":"56","author":"Oshimi","year":"2017","journal-title":"Intern Med."},{"key":"B4","first-page":"1343","article-title":"Aggressive natural killer cell leukemia: clinical features and treatment outcome","volume":"87","author":"Song","year":"2002","journal-title":"Haematologica"},{"key":"B5","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/sj.leu.2403262","article-title":"Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells","volume":"18","author":"Suzuki","year":"2004","journal-title":"Leukemia"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1349-7006.2012.02251.x","article-title":"Aggressive natural killer cell leukemia: therapeutic potential of L-asparaginase and allogeneic hematopoietic stem cell transplantation","volume":"103","author":"Ishida","year":"2012","journal-title":"Cancer Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1172\/JCI114168","article-title":"CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA","volume":"84","author":"Kawa-Ha","year":"1989","journal-title":"J Clin Invest."},{"key":"B8","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/j.1365-2141.1995.tb05587.x","article-title":"The detection of clonal proliferation in granular lymphocyte-proliferative disorders of natural killer cell lineage","volume":"90","author":"Shimodaira","year":"1995","journal-title":"Br J Haematol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000193225","article-title":"Aggressive natural killer cell leukemia: is Epstein-Barr virus negativity an indicator of a favorable prognosis?","volume":"120","author":"Ko","year":"2008","journal-title":"Acta Haematol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13045-016-0271-4","article-title":"L-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia","volume":"9","author":"Jung","year":"2016","journal-title":"J Hematol Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1182\/blood-2016-08-692590","article-title":"LGL leukemia: from pathogenesis to treatment","volume":"129","author":"Lamy","year":"2017","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1532\/IJH97.A10612","article-title":"Aggressive natural killer cell leukemia: report of a Chinese series and review of the literature","volume":"85","author":"Ryder","year":"2007","journal-title":"Int J Hematol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","article-title":"EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases","volume":"119","author":"Kimura","year":"2012","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/jclinpath-2011-200523","article-title":"T\/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T\/NK-cell lymphoma","volume":"65","author":"Isobe","year":"2012","journal-title":"J Clin Pathol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1080\/10428190400004513","article-title":"Aggressive natural killer-cell leukemia: report of five cases and review of the literature","volume":"45","author":"Ruskova","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"B16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1365-2141.1990.tb02615.x","article-title":"Aggressive natural killer cell leukaemia\/lymphoma: report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells","volume":"75","author":"Imamura","year":"1990","journal-title":"Br J Haematol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41408-017-0021-z","article-title":"Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes","volume":"7","author":"Tang","year":"2017","journal-title":"Blood Cancer J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/PAS.0000000000000735","article-title":"EBV-negative aggressive NK-cell leukemia\/lymphoma: clinical, pathologic, and genetic features","volume":"41","author":"Nicolae","year":"2017","journal-title":"Am J Surg Pathol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1046\/j.1365-2141.1998.01109.x","article-title":"Clonal disease of natural killer large granular lymphocytes in Taiwan","volume":"103","author":"Chou","year":"1998","journal-title":"Br J Haematol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"882","DOI":"10.2169\/internalmedicine.32.882","article-title":"Aggressive granular lymphocyte leukemia of natural killer cell type in an elderly patient","volume":"32","author":"Ichikawa","year":"1993","journal-title":"Intern Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1097\/PAS.0000000000000634","article-title":"Clinicopathologic characterization of aggressive natural killer cell leukemia involving different tissue sites","volume":"40","author":"Gao","year":"2016","journal-title":"Am J Surg Pathol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"962","DOI":"10.3109\/10428194.2013.819577","article-title":"Rare occurrence of JAK3 mutations in natural killer cell neoplasms in Japan","volume":"55","author":"Kimura","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/s41467-018-03987-2","article-title":"Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target","volume":"9","author":"Dufva","year":"2018","journal-title":"Nat Commun."},{"key":"B24","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/cr.2017.146","article-title":"Integrated genomic analysis identifies deregulated JAK\/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia","volume":"28","author":"Huang","year":"2018","journal-title":"Cell Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/sj.leu.2403732","article-title":"Significance of chemokine receptor expression in aggressive NK cell leukemia","volume":"19","author":"Makishima","year":"2005","journal-title":"Leukemia"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.leukres.2006.10.020","article-title":"Chemokine system and tissue infiltration in aggressive NK-cell leukemia","volume":"31","author":"Makishima","year":"2007","journal-title":"Leuk Res."},{"key":"B27","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1182\/blood.V93.10.3494.410k14_3494_3504","article-title":"Interferon-gamma prevents apoptosis in Epstein-Barr virus-infected natural killer cell leukemia in an autocrine fashion","volume":"93","author":"Mizuno","year":"1999","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/sj.leu.2403261","article-title":"DNA microarray analysis of natural killer cell-type lymphoproliferative disease of granular lymphocytes with purified CD3\u2212CD56+ fractions","volume":"18","author":"Choi","year":"2004","journal-title":"Leukemia"},{"key":"B29","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/gcc.20245","article-title":"Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma\/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal NK\/T-cell lymphoma, nasal type","volume":"44","author":"Nakashima","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/leu.2009.3","article-title":"Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies","volume":"23","author":"Iqbal","year":"2009","journal-title":"Leukemia"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1093\/annonc\/mdp418","article-title":"Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type","volume":"21","author":"Suzuki","year":"2010","journal-title":"Ann Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s12185-012-1159-x","article-title":"Elevated serum granulysin and its clinical relevance in mature NK-cell neoplasms","volume":"96","author":"Sekiguchi","year":"2012","journal-title":"Int J Hematol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/j.1365-2559.2011.03976.x","article-title":"Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)\/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders","volume":"59","author":"Takahashi","year":"2011","journal-title":"Histopathology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/j.1365-2141.2005.05694.x","article-title":"Selective apoptosis of natural killer-cell tumours by l-asparaginase","volume":"130","author":"Ando","year":"2005","journal-title":"Br J Haematol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1600-0609.2008.01090.x","article-title":"Promising approach for aggressive NK cell leukaemia with allogeneic haematopoietic cell transplantation","volume":"81","author":"Ito","year":"2008","journal-title":"Eur J Haematol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.trsl.2014.01.010","article-title":"Abnormal immunophenotype provides a key diagnostic marker: a report of 29 cases of de novo aggressive natural killer cell leukemia","volume":"163","author":"Li","year":"2014","journal-title":"Transl Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/MAJ.0b013e3182764b59","article-title":"Adult aggressive natural killer cell leukemia","volume":"346","author":"Zhang","year":"2013","journal-title":"Am J Med Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.bbmt.2017.01.082","article-title":"Allogeneic hematopoietic cell transplantation for aggressive NK cell leukemia. A center for international blood and marrow transplant research analysis","volume":"23","author":"Hamadani","year":"2017","journal-title":"Biol Blood Marrow Transplant."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/s0140-6736(96)90325-6","article-title":"Bone-marrow transplantation for Epstein-Barr-virus-associated natural killer cell-large granular lymphocyte leukaemia","volume":"347","author":"Teshima","year":"1996","journal-title":"Lancet"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/sj.bmt.1701262","article-title":"Successful treatment of Epstein-Barr virus-associated natural killer cell large granular lymphocytic leukaemia using allogeneic peripheral blood stem cell transplantation","volume":"21","author":"Takami","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1182\/blood-2016-12-756841","article-title":"PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK\/T-cell lymphoma failing l-asparaginase","volume":"129","author":"Kwong","year":"2017","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13045-018-0559-7","article-title":"Activity of pembrolizumab in relapsed\/refractory NK\/T-cell lymphoma","volume":"11","author":"Li","year":"2018","journal-title":"J Hematol Oncol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.canlet.2012.12.022","article-title":"Comprehensive gene expression profiles of NK cell neoplasms identify vorinostat as an effective drug candidate","volume":"333","author":"Karube","year":"2013","journal-title":"Cancer Lett."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2018.00292\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T00:08:45Z","timestamp":1572048525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2018.00292\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,10]]},"references-count":43,"alternative-id":["10.3389\/fped.2018.00292"],"URL":"https:\/\/doi.org\/10.3389\/fped.2018.00292","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,10]]},"article-number":"292"}}